News
Inherited antithrombin deficiency: a review
Summary. Antithrombin (AT) is a potent inactivator of thrombin and factor Xa and the major …
New Antithrombin Drug, ATryn, Approved by FDA
ATryn, an anticoagulant, is the first ever biologic product produced by a genetically …
Athletes – Blood clots can’t stop them… not even contain them!
By: Roland Varga, aka “The Clot Buster” Originally Published the Summer of 2006 – …
NBCA Announces New Stoplight Risk Evaluation Tool For Blood Clots
For Immediate Release Tuesday, March 10, 2009 – Tarrytown NY – NBCA unveiled the …
INR Home Monitoring Triumphs! CMS Expands Coverage
Good news! The Center for Medicare and Medicaid Services (CMS) is expanding its coverage of …
Family Testing for Clotting Disorders
By: Elizabeth Varga, MS A “genetic thrombophilia,” or an inherited predisposition to develop …
NBCA-MN Announces September Support Group Meeting
For Immediate Release Saint Paul, MN, August 14, 2009 – The National Alliance for Thrombosis …
NBCA Launches Nationwide Chapter Development Strategy
The Board of Directors of the National Alliance for Thrombosis & Thrombophilia (NBCA) has …
Blood Clot Statistics Vary – What to do About it?
WHAT’S IN A NUMBER? By Alan P. Brownstein 2,000,000, 900,000, 350,000, 600,000 – how many blood …
FDA Panel Recommends Approval Of New Oral Anticoagulant For Hip/Knee Surgery
NBCA’S HENRY ADDRESSES FDA PANEL For Immediate Release Tarrytown NY, March 20, 2009 – …
